,,Ib

Patrick A Ott1, Siwen Hu-Lieskovan2, Bartosz Chmielowski2

  • 1Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.

Cell
|October 16, 2020
PubMed
まとめ

パーソナライズされたがんワクチン (NEO- PV-01) はPD-1阻害と組み合わせて安全で,進行がんの患者で強固なT細胞反応を生成します. この治療は腫瘍を標的とした免疫細胞を活性化させ,メラノーマ,肺,膀がん患者で有望な結果を示した.

関連する概念動画

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K